Moolec Science (MLEC, Financial) has achieved a significant milestone by obtaining a Notice of Allowance from the United States Patent and Trademark Office for its innovative Piggy Sooy technology. This technology involves engineering soybean plants to produce high levels of porcine hemeproteins in their seeds. The newly granted U.S. patent encompasses the plants, seeds, the development method, and food compositions derived from this technological advance.
In April 2024, the USDA-APHIS verified that the Piggy Sooy technology does not differ in plant pest risk from conventional soybeans, exempting it from regulation under 7 CFR part 340. This patent secures Moolec exclusive commercial rights to the Piggy Sooy innovation in the U.S. until the year 2042.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Moolec Science SA (MLEC, Financial) is $30.00 with a high estimate of $30.00 and a low estimate of $30.00. The average target implies an upside of 338.28% from the current price of $6.85. More detailed estimate data can be found on the Moolec Science SA (MLEC) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Moolec Science SA's (MLEC, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
